Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Thrombosis and Haemostasis
|
September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery
Job Harenberg, Svetlana Marx, Ola E Dahl, et al.
Thrombosis and Haemostasis
|
October 7, 2022
Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals
Azita H Talasaz, Parham Sadeghipour, Kasra Mehdizadeh, et al.
BMC Nephrology
|
June 30, 2012
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study
Oliver Dorsch, Detlef H Krieter, Horst-Dieter Lemke, et al.
Thrombosis Research
|
May 18, 2024
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting
Julie Vassart, Alfonso Tafur, Marisa Durante, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
June 6, 2023
Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants
Loula Papageorgiou, Svetlana Hetjens, Jawed Fareed, et al.
Thrombosis and Haemostasis
|
November 10, 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial
Job Harenberg, Jan Beyer-Westendorf, Mark Crowther, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
October 1, 2021
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysis
Andrea Martini, Job Harenberg, Rupert Bauersachs, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 7, 2008
AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation
Ulrich Tebbe, Ralph Oeckinghaus, Karl-Friedrich Appel, et al.
Cerebrovascular Diseases Extra
|
June 9, 2026
Feasibility of DOAC Dipstick point-of-care testing in patients with acute stroke and transient ischemic attack
Maximilian Ziegler, Kristina Szabo, Carolin Hoyer, et al.
European Journal of Clinical Investigation
|
June 17, 2014
Measurement of rivaroxaban and apixaban in serum samples of patients
Job Harenberg, Sandra Krämer, Shanshan Du, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Thrombosis and Haemostasis
|
September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery
Job Harenberg, Svetlana Marx, Ola E Dahl, et al.
Thrombosis and Haemostasis
|
October 7, 2022
Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals
Azita H Talasaz, Parham Sadeghipour, Kasra Mehdizadeh, et al.
BMC Nephrology
|
June 30, 2012
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study
Oliver Dorsch, Detlef H Krieter, Horst-Dieter Lemke, et al.
Thrombosis Research
|
May 18, 2024
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting
Julie Vassart, Alfonso Tafur, Marisa Durante, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
June 6, 2023
Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants
Loula Papageorgiou, Svetlana Hetjens, Jawed Fareed, et al.
Thrombosis and Haemostasis
|
November 10, 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial
Job Harenberg, Jan Beyer-Westendorf, Mark Crowther, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
October 1, 2021
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysis
Andrea Martini, Job Harenberg, Rupert Bauersachs, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 7, 2008
AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation
Ulrich Tebbe, Ralph Oeckinghaus, Karl-Friedrich Appel, et al.
Cerebrovascular Diseases Extra
|
June 9, 2026
Feasibility of DOAC Dipstick point-of-care testing in patients with acute stroke and transient ischemic attack
Maximilian Ziegler, Kristina Szabo, Carolin Hoyer, et al.
European Journal of Clinical Investigation
|
June 17, 2014
Measurement of rivaroxaban and apixaban in serum samples of patients
Job Harenberg, Sandra Krämer, Shanshan Du, et al.
Page
of 11